Inhibition and Structural Changes of Liver Alkaline Phosphatase by Tramadol

ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)


Volume 8, 2 Issues, 2014


Download PDF Flyer




Drug Metabolism Letters

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Chandra Prakash
Department of Drug Metabolism and Pharmacokinetics
Biogen Idec
Cambridge, MA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Inhibition and Structural Changes of Liver Alkaline Phosphatase by Tramadol

Author(s): Dariush Minai-Tehrani

Affiliation: Bioresearch Lab, Faculty of Biological sciences, Shahid Beheshti University, Iran

Abstract

Tramadol is a potent analgesic drug which interacts with mu-opioid and has low effect on other opioid receptors. Unlike other opioids, it has no clinically significant effects on respiratory or cardiovascular parameters. Alakaline phosphatase is a hydrolase enzyme that prefers alkaline condition and removes phosphate group from different substrates. In this study, the interaction between tramadol and calf liver alkaline phosphatase was investigated. The results showed that tramadol can bind to alakaline phosphatase and inhibit the enzyme in an un-competitive manner. Ki and IC50 values of tramadol were determined as about 91 and 92 μM, respectively. After enzyme purification, structural changes on alakaline phosphatase-drug interaction were studied by circular dichroism and fluorescence measurement. These data revealed that the alteration in the content of secondary structures and also conformational changes in enzyme occurred when the drug bound to enzyme-substrate complex

Keywords: Conformational changes, drug, enzyme, inhibition

Purchase Online Rights and Permissions

Article Details

Volume: 8
First Page: 1
Last Page: 6
Page Count: 6
DOI: 10.2174/1872312808666140506093756
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science